Application of Assisted Design of Antibody and Protein Therapeutics (ADAPT) improves efficacy of a Clostridium difficile toxin a single-domain antibody

From National Research Council Canada

  1. (PDF, 1.3 MiB)
DOIResolve DOI:
AuthorSearch for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1
Name affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FormatText, Article
Publication date
PublisherNature Publishing Group
Peer reviewedYes
NPARC number23002892
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifier8467c362-ce77-4829-a8db-01b30a8a0bdf
Record created2018-03-21
Record modified2020-05-30
Date modified: